Q3 2025 Holdings
Filed 2025-11-14 | 29 holdings | $666.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $46.1M | 319,773 | 6.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $41.8M | 570,569 | 6.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $35.8M | 85,318 | 5.4% |
| Merus N V | COM | N5749R100 | $35.0M | 372,022 | 5.3% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $34.1M | 394,754 | 5.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $32.1M | 799,743 | 4.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $30.6M | 589,729 | 4.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $30.0M | 643,050 | 4.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $29.1M | 146,291 | 4.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $28.6M | 38,767 | 4.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $26.3M | 397,693 | 3.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $25.9M | 2,159,474 | 3.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $25.8M | 313,733 | 3.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $25.5M | 181,897 | 3.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $24.8M | 291,820 | 3.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $20.4M | 716,971 | 3.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $18.9M | 397,010 | 2.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $18.5M | 152,614 | 2.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $16.0M | 783,411 | 2.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $16.0M | 402,811 | 2.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $15.7M | 277,726 | 2.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $15.6M | 639,699 | 2.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $14.5M | 959,703 | 2.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.0M | 254,795 | 2.1% |
| Natera Inc(NTRA) | COM | 632307104 | $13.0M | 80,875 | 2.0% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $11.9M | 808,673 | 1.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $10.3M | 354,529 | 1.5% |
| Harrow Inc(HROW) | COM | 415858109 | $7.7M | 160,234 | 1.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.9M | 262,643 | 0.3% |